BE1002310A4 - Medicament pour le traitement de l'osteoporose. - Google Patents

Medicament pour le traitement de l'osteoporose. Download PDF

Info

Publication number
BE1002310A4
BE1002310A4 BE8900276A BE8900276A BE1002310A4 BE 1002310 A4 BE1002310 A4 BE 1002310A4 BE 8900276 A BE8900276 A BE 8900276A BE 8900276 A BE8900276 A BE 8900276A BE 1002310 A4 BE1002310 A4 BE 1002310A4
Authority
BE
Belgium
Prior art keywords
treatment
osteoporosis
medicine
progestin
unsubstituted
Prior art date
Application number
BE8900276A
Other languages
English (en)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888806028A external-priority patent/GB8806028D0/en
Priority claimed from GB888813740A external-priority patent/GB8813740D0/en
Application filed by Sandoz Sa filed Critical Sandoz Sa
Application granted granted Critical
Publication of BE1002310A4 publication Critical patent/BE1002310A4/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

L'invention concerne l'utilisation d'un progestatif non substitué en position 19 dans la fabrication d'un médicament pour le traitement, sur une base non cyclique, de l'ostéoporose établie.
BE8900276A 1988-03-14 1989-03-14 Medicament pour le traitement de l'osteoporose. BE1002310A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888806028A GB8806028D0 (en) 1988-03-14 1988-03-14 Improvements in/relating to organic compounds
GB888813740A GB8813740D0 (en) 1988-06-10 1988-06-10 Improvements in/relating to organic compounds

Publications (1)

Publication Number Publication Date
BE1002310A4 true BE1002310A4 (fr) 1990-11-27

Family

ID=26293634

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8900276A BE1002310A4 (fr) 1988-03-14 1989-03-14 Medicament pour le traitement de l'osteoporose.

Country Status (13)

Country Link
EP (1) EP0337938A3 (fr)
JP (1) JPH029820A (fr)
AU (1) AU3131389A (fr)
BE (1) BE1002310A4 (fr)
CH (1) CH678814A5 (fr)
DE (1) DE3908130A1 (fr)
DK (1) DK120389A (fr)
FR (1) FR2628321A1 (fr)
GB (1) GB2216420B (fr)
HU (1) HUT52382A (fr)
IT (1) IT1232822B (fr)
NL (1) NL8900610A (fr)
SE (1) SE8900875L (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8166191A (en) * 1990-08-10 1992-02-13 Ortho Pharmaceutical Corporation Method for treatment of bone wasting diseases
ZA94715B (en) * 1993-02-08 1994-10-24 Akzo Nv Steroids for treating menopausal complaints
US5710144A (en) * 1993-02-08 1998-01-20 Akzo Nobel N.V. C-11 substituted steroids for treating menopausal complaints
US6037339A (en) 1993-02-08 2000-03-14 Akzo Nobel N.V. C-11 substituted steroids for treating menopausal complaints
US5591753A (en) * 1994-01-28 1997-01-07 Eli Lilly And Company Combination treatment for osteoporosis
DE4405590C1 (de) * 1994-02-22 1995-07-20 Hesch Rolf Dieter Prof Dr Med Mittel zur postmenopausalen Hormonbehandlung
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
ES2933479T3 (es) 2003-09-29 2023-02-09 Novo Nordisk Healthcare Ag Estabilidad mejorada de formulaciones de progestágenos
CN101869080B (zh) * 2010-06-08 2012-10-03 中国水产科学研究院渔业机械仪器研究所 一种网箱污物收集装置

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0235090A1 (fr) * 1986-02-27 1987-09-02 Warner-Lambert Company Composé apte au traitement des déficiences en oestrogènes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB235090A (en) * 1924-06-26 1925-06-11 Hermann Haas Cloth shearing machines
US4425339A (en) * 1981-04-09 1984-01-10 Syntex (U.S.A.) Inc. Treatment of menopausal symptoms
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
CH674618A5 (fr) * 1987-04-02 1990-06-29 Ciba Geigy Ag

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0235090A1 (fr) * 1986-02-27 1987-09-02 Warner-Lambert Company Composé apte au traitement des déficiences en oestrogènes

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ACTA OBSTET. GYNECOL. SCAND. SUPPL., vol. 130, 1985, pages 53-58; L.-A. MATTSON et al.: "Estrogen-progestogen replacement in climacteric women, particularly as regards a new type of continuous regimen" *
BR. J. HOSP. MED., vol. 38, no. 5, 1987, pages 484-485; P.L. SELBY et al.: "Norethisterone in postmenopausal osteoporosis" *
CLIN. SCI. MOL. MED., vol. 54, no. 2, 1978, pages 193-195; R. LINDSAY et al.: "Comparative effects of oestrogen and a progestogen on bone loss in postmenopausal women" *
CLINICAL ENDOCRINOLOGY, vol. 16, no. 5, 1982, pages 515-524, Blackwell Scientific Publications; G.F. JENSEN et al.: "Treatment of post menopausal osteoporosis. A controlled therapeutic trial comparing oestrogen/gestagen, 1,25-dihydroxy-vitamin D, and calcium" *
MATURITAS, vol. 8, no. 4, 1986, pages 267-274, Elsevier Scinece Publishers B.V., Amsterdam, NL; B.J. RIIS et al.: "Post-menopausal bone loss: effects of oestrogens and progestogens. A review" *
OBSTET. GYNECOL., vol. 66, no. 6, décembre 1985, pages 789-792; H.I. ABDALLA et al.: "Prevention of bone mineral loss in postmenopausal women by norethisterone" *

Also Published As

Publication number Publication date
DE3908130A1 (de) 1989-10-05
SE8900875L (sv) 1989-12-15
JPH029820A (ja) 1990-01-12
GB2216420B (en) 1991-12-11
NL8900610A (nl) 1989-10-02
DK120389D0 (da) 1989-03-13
SE8900875D0 (sv) 1989-03-13
DK120389A (da) 1989-09-15
IT1232822B (it) 1992-03-05
AU3131389A (en) 1989-09-14
CH678814A5 (fr) 1991-11-15
HUT52382A (en) 1990-07-28
FR2628321A1 (fr) 1989-09-15
EP0337938A3 (fr) 1990-09-12
EP0337938A2 (fr) 1989-10-18
GB8905714D0 (en) 1989-04-26
GB2216420A (en) 1989-10-11
IT8947740A0 (it) 1989-03-14

Similar Documents

Publication Publication Date Title
DZ1077A1 (fr) Nouvelles préparation pharmaceutique pour administration orale.
IL84425A (en) (s) - (+) -ibuprofen-containing pharmaceutical compositions
FR2600886B1 (fr) Matieres pour empreintes dentaires precises comprenant du silicone.
OA09117A (fr) Utilisation d'une composition pour le traitement en surface de sols.
FR2345135A1 (fr) Moteur d'entrainement pour une piece a main, eventuellement coudee, de dentisterie
FI875020A7 (fi) Terapeuttiset aineet.
EP0601058A4 (fr) Formulations transdermiques pour l'administration de prazosine.
BE1002310A4 (fr) Medicament pour le traitement de l'osteoporose.
EP0602798A3 (fr) Structure pour l'utilisation d'une portion de circuit intégré.
NL960024I2 (nl) Farmaceutisch preparaat omvattend 3'-deoxythymidine-2'-een (3'-deoxy-2',3'-didehydrothymidine) voor de behandeling van met retrovirus besmette patiënten.
FR2499408B1 (fr) Composition pharmaceutique pour le traitement de l'osteopathie, a base d'acide 6-amino-1-hydroxyhexane-1,1-diphosphonique
FR2651344B1 (fr) Processeur d'assemblage pour base de donnees relationnelles.
FI874166A7 (fi) 2',3'-dideoksisytidin-2'-eenin käyttö retroviruksilla infektoituneiden potilaiden hoitoon.
OA08406A (fr) Préparation de combinaison pour le traitement de la malaria.
FR2645592B1 (fr) Procede pour le fonctionnement d'une unite motrice, excavateur ou analogues
USD278630S (en) Console faceplate for teleconferencing bridge
FR2658419B1 (fr) Medicament pour le traitement de la dermatite.
FR2714603B1 (fr) Composition dermatologique et son utilisation pour la préparation d'un médicament.
CA2166318A1 (fr) Compositions pharmaceutiques et leur utilisation, notamment pour le traitement des maladies neurodegeneratives
FR2659555B3 (fr) Preparation a base de farine(s) pour le traitement du corps, par voie externe, notamment en pediluve dynamique.
FR2705568B1 (fr) Utilisation de lipides peroxydés pour la préparation d'une composition pharmaceutique destinées au traitement par application locale des télangiectasies.
SU976138A2 (ru) Сифонный дозатор
FR2713087B1 (fr) Utilisation de la sélégiline et ses dérivés pour la préparation d'un médicament destiné au traitement du psoriasis.
FR1130M (fr) Médicament a base de 10[1',3'-diméthyl-pyrrolidly-(3')-méthyl]-phénothiazine pour le traitement de maladies mentales.
FR2691064B3 (fr) Nouveau medicament pour le traitement de l'arythmie.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: S.A. SANDOZ

Effective date: 19930331